Cannabis Use, Knowledge, and Counseling Needs During Pregnancy and Early Parenthood
Related Experiment Video
Updated: Nov 6, 2026

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Sarah S Gelinas1, Zachary Giano2, Ann Futterman Collier3
1Rocky Mountain Prevention Research Center, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Introduction:
Cannabis use during pregnancy and early parenthood is an increasing public health concern, particularly as high-concentration cannabis (HCC) products have become more widely available. Although prior research has examined perinatal cannabis use and risk perceptions, less is known about cannabis knowledge, HCC use, and confidence in risk-reduction behaviors across stages of early parenthood. This study compared these factors among parents at different stages of parenthood.
Methods:
This cross-sectional study analyzed data from an online survey panel of adults living in Colorado. Of 630 initial respondents, 564 completed at least 80% of survey items; 327 identified as parents and were included in this analysis. Analyses compared participants who were pregnant or parenting a child aged younger than 2 years, defined as the early parenthood group (n = 76), with parents of children aged older than 2 years, defined as the older parenthood group (n = 256). Survey items assessed cannabis or HCC use, product and health-related knowledge, perceived harms, and self-efficacy intentions. Group differences were examined using χ2 tests and analysis of variance.
Results:
Current cannabis use was similar between groups. HCC use was higher in the early parenthood group than in the older parenthood group, but this difference was not statistically significant (22.4% vs 14.1%; P = .08). When compared with the older parenthood group, the early parenthood group had lower health-related knowledge scores (P = .01), lower overall knowledge scores (P = .03), lower confidence in declining HCC (P = .007), and lower confidence in choosing alternatives (P = .009).
Discussion:
The early parenthood group demonstrated lower cannabis knowledge and confidence in risk-reduction behaviors than the older parenthood group. Findings highlight the need for counseling that addresses cannabis potency, perceived risks and benefits, and practical skills for reducing use during pregnancy and early parenthood.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains delta-9-tetrahydrocannabinol (THC)...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Altered States of Awareness
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain that...
Teratogenicity
